Risk reduction therapies for patients with coronary artery disease: a call for increased implementation

Area of Science:

• Cardiology
• Preventive Medicine
• Public Health

Background:

• Significant advancements in interventional procedures and medical therapies for obstructive coronary artery disease (CAD) have been achieved.
• However, progress in understanding and implementing preventive therapy and risk reduction for CAD has been limited.
• The traditional focus on treating severe coronary obstruction addresses only a portion of the overall problem.

Purpose of the Study:

• To advocate for a comprehensive approach to atherosclerotic disease, encompassing the entire spectrum from prevention to treatment.
• To highlight the underutilization of evidence-based risk-reduction strategies in cardiovascular disease (CVD) care.
• To emphasize the need for systemic changes in healthcare delivery to integrate risk-reduction therapies into routine patient care.

Main Methods:

• Review of clinical trial evidence demonstrating the efficacy of risk-reduction strategies.
• Analysis of current healthcare practices regarding cardiovascular disease management.
• Identification of barriers to the implementation of preventive therapies.

Main Results:

• Numerous clinical trials confirm that risk-reduction strategies significantly decrease cardiovascular events and total mortality.
• Despite strong evidence, preventive therapies for cardiovascular disease remain underutilized in clinical practice.
• Current healthcare delivery systems often fail to prioritize or integrate comprehensive risk-reduction strategies.

Conclusions:

• A paradigm shift towards a holistic approach to atherosclerotic disease is necessary, addressing both treatment and prevention.
• Effective implementation of risk-reduction strategies requires systemic changes within healthcare delivery.
• Integrating preventive care is essential for improving patient outcomes and reducing the burden of cardiovascular disease.